We are live on ! Find out more
GUTS icon

Fractyl Health

65 hedge funds and large institutions have $53.4M invested in Fractyl Health in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 23 increasing their positions, 11 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

109% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 11

40% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 10

7% more funds holding

Funds holding: 6165 (+4)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

0.08% less ownership

Funds ownership: 53.93%53.85% (-0.08%)

18% less capital invested

Capital invested by funds: $65.4M → $53.4M (-$12M)

Holders
65
Holders Change
+4
Holders Change %
+6.56%
% of All Funds
0.85%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
14
Increased
23
Reduced
11
Closed
10
Calls
Puts
Net Calls
Net Calls Change

GUTS Hedge Fund Activity: Q4 2024 in Review

65 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Fractyl Health (GUTS) for Q4 2024, worth a combined $53.4M — down 18% from $65.4M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new GUTS positions and 10 closed out — a net gain of 4 holders — while 23 added to existing stakes and 11 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.85M. The largest seller was Ensign Peak Advisors, exiting entirely with an estimated $3.56M sold.

  • 65 institutional investors held Fractyl Health (GUTS) as of Q4 2024, up from 61 in Q3 2024.
  • Funds reported $53.4M of Fractyl Health stock for Q4 2024, down 18% quarter-over-quarter.
  • 14 funds opened new Fractyl Health positions in Q4 2024 and 10 closed out, a net change of +4 holders.
  • The largest Fractyl Health buyer in Q4 2024 was Vanguard Group, an estimated $1.85M added.
  • The largest Fractyl Health seller in Q4 2024 was Ensign Peak Advisors, an estimated $3.56M sold.

Based on aggregated 13F filings for Q4 2024.